Gary Clark: Unfiltered

As Ranger Energy Services preps its Q2 report, investors are watching. Will strategic bets pay off, or will profitability misses continue to haunt the stock?

After a record-setting boom, Prince Edward Island's construction sector is slowing. This moderation creates a surplus of skilled labor and a critical challenge.

Lockheed Martin's new, cheaper PAC-3 ACE missile isn't just new hardware; it's a strategic pivot addressing the unsustainable economics of air defense.

The real estate giant slashed its dividend by over 95%. It’s not a retreat, but a bold move to fund a war chest for AI and acquisitions in a consolidating market.

As Brilliant Earth preps its Q2 results, the firm faces a critical test. Is its celebrated ethical model a true market moat or a luxury in a downturn?

The American Academy of Pediatrics is plugging its gold-standard guidance into an AI brain. It’s a move set to transform pediatric care and a major test for AI.

Joel Gott Wines, a name synonymous with quality bottled wine, is entering the RTD fray with Sauvy B. Is this a savvy diversification or a risky departure?

A new bispecific antibody from Kelun-Biotech and Harbour BioMed just got a green light in China, promising quarterly doses for asthma. Is this the innovation that finally unseats the market giants?

Mesabi Trust's drastic 58% distribution cut reveals more than just lower royalties. It's a stark warning about market volatility and Cleveland-Cliffs' strategy.

A federal judge sanctions top DOJ officials over a 'collusive' $1.8B Trump settlement, exposing a brazen attempt to subvert the law for political gain.

Godspeed Capital's ICE USA platform acquires a key land acquisition firm, a strategic move to create a one-stop-shop for booming public works projects.

Silverstein Properties is now offering AI-powered workplace analytics as an amenity. This isn't just a perk; it's a structural shift in real estate value.

German fintech Pliant enters the crowded U.S. market, challenging giants like Ramp and Brex. Is its API-first infrastructure model the key to winning?

With ASTM approval secured and mandates looming, Argus Media's new methanol-to-jet index provides the pricing transparency needed to fuel aviation's costly green transition.

As HESM preps its Q2 earnings call, the market is watching. Beyond the numbers, it's a test of its fee-based model against Bakken's pulse.

Eupraxia Pharmaceuticals is overhauling its leadership and relocating to major biotech hubs, betting it all on its late-stage pipeline and a pivotal trial.

A rare mid-year IRS mileage rate hike to 76 cents isn't just about gas prices. It's a signal of persistent volatility forcing a strategic rethink.

Comvest Private Equity is now Vesterra Capital Partners. This isn't a pivot, but a strategic sharpening of its operational playbook in a crowded market.

With a $150M war chest, Wire 3 is challenging broadband giants in Florida. Is their 10-gigabit fiber gambit a true game-changer or just another headline?

A biotech's preclinical success in treating miscarriage is just the start. The real story is its strategy of using pregnancy immunology to target cancer.